BeOne Medicines (ONC) Competitors $324.34 -11.33 (-3.38%) As of 09/12/2025 04:00 PM Eastern Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock ONC vs. SNY, GSK, TAK, ARGX, INSM, BNTX, TEVA, SMMT, GMAB, and ASNDShould you be buying BeOne Medicines stock or one of its competitors? The main competitors of BeOne Medicines include Sanofi (SNY), GSK (GSK), Takeda Pharmaceutical (TAK), argenex (ARGX), Insmed (INSM), BioNTech (BNTX), Teva Pharmaceutical Industries (TEVA), Summit Therapeutics (SMMT), Genmab A/S (GMAB), and Ascendis Pharma A/S (ASND). These companies are all part of the "pharmaceutical products" industry. BeOne Medicines vs. Its Competitors Sanofi GSK Takeda Pharmaceutical argenex Insmed BioNTech Teva Pharmaceutical Industries Summit Therapeutics Genmab A/S Ascendis Pharma A/S BeOne Medicines (NASDAQ:ONC) and Sanofi (NASDAQ:SNY) are both large-cap medical companies, but which is the superior business? We will compare the two businesses based on the strength of their institutional ownership, dividends, valuation, risk, analyst recommendations, media sentiment, earnings and profitability. Which has more risk and volatility, ONC or SNY? BeOne Medicines has a beta of 0.21, indicating that its share price is 79% less volatile than the S&P 500. Comparatively, Sanofi has a beta of 0.51, indicating that its share price is 49% less volatile than the S&P 500. Do institutionals & insiders believe in ONC or SNY? 48.5% of BeOne Medicines shares are held by institutional investors. Comparatively, 14.0% of Sanofi shares are held by institutional investors. 6.6% of BeOne Medicines shares are held by insiders. Comparatively, 1.0% of Sanofi shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth. Does the media favor ONC or SNY? In the previous week, Sanofi had 6 more articles in the media than BeOne Medicines. MarketBeat recorded 24 mentions for Sanofi and 18 mentions for BeOne Medicines. Sanofi's average media sentiment score of 0.90 beat BeOne Medicines' score of 0.39 indicating that Sanofi is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment BeOne Medicines 6 Very Positive mention(s) 2 Positive mention(s) 5 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Neutral Sanofi 11 Very Positive mention(s) 1 Positive mention(s) 8 Neutral mention(s) 2 Negative mention(s) 0 Very Negative mention(s) Positive Is ONC or SNY more profitable? Sanofi has a net margin of 21.47% compared to BeOne Medicines' net margin of -3.89%. Sanofi's return on equity of 16.86% beat BeOne Medicines' return on equity.Company Net Margins Return on Equity Return on Assets BeOne Medicines-3.89% -1.22% -0.72% Sanofi 21.47%16.86%9.63% Do analysts rate ONC or SNY? BeOne Medicines presently has a consensus target price of $330.89, indicating a potential upside of 2.02%. Sanofi has a consensus target price of $62.67, indicating a potential upside of 33.25%. Given Sanofi's stronger consensus rating and higher probable upside, analysts plainly believe Sanofi is more favorable than BeOne Medicines.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score BeOne Medicines 0 Sell rating(s) 0 Hold rating(s) 7 Buy rating(s) 0 Strong Buy rating(s) 3.00Sanofi 0 Sell rating(s) 1 Hold rating(s) 6 Buy rating(s) 3 Strong Buy rating(s) 3.20 Which has better valuation and earnings, ONC or SNY? Sanofi has higher revenue and earnings than BeOne Medicines. BeOne Medicines is trading at a lower price-to-earnings ratio than Sanofi, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioBeOne Medicines$4.56B7.79-$644.79M-$1.73-187.48Sanofi$45.74B2.52$6.02B$4.1611.31 SummarySanofi beats BeOne Medicines on 13 of the 17 factors compared between the two stocks. Get BeOne Medicines News Delivered to You Automatically Sign up to receive the latest news and ratings for ONC and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding ONC and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart ONC vs. The Competition Export to ExcelMetricBeOne MedicinesMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$35.55B$2.59B$5.84B$10.14BDividend YieldN/A56.52%5.68%4.60%P/E Ratio-187.4823.8575.4125.98Price / Sales7.79529.66515.81181.13Price / CashN/A171.1637.5660.44Price / Book9.515.3712.156.29Net Income-$644.79M$32.95M$3.29B$271.07M7 Day Performance-5.11%1.28%0.73%3.87%1 Month Performance4.73%5.61%4.99%5.49%1 Year PerformanceN/A-1.67%62.53%25.86% BeOne Medicines Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)ONCBeOne Medicines1.8004 of 5 stars$324.34-3.4%$330.89+2.0%N/A$35.55B$4.56B-187.4811,000News CoverageInsider TradeSNYSanofi3.9845 of 5 stars$46.50+2.6%$62.00+33.3%-17.7%$111.31B$44.46B11.1882,878High Trading VolumeGSKGSK2.1997 of 5 stars$40.41+2.0%$37.38-7.5%-5.1%$82.49B$31.63B18.7168,629Positive NewsDividend CutHigh Trading VolumeTAKTakeda Pharmaceutical2.478 of 5 stars$15.40+0.7%N/A+2.8%$48.65B$30.09B51.3247,455ARGXargenex4.0008 of 5 stars$750.78+2.3%$772.84+2.9%+40.6%$45.95B$3.05B38.501,599News CoveragePositive NewsAnalyst DowngradeINSMInsmed3.3317 of 5 stars$145.10+1.8%$134.79-7.1%+95.5%$30.13B$363.71M-25.411,271Positive NewsBNTXBioNTech2.5143 of 5 stars$112.46+8.7%$135.80+20.8%-21.6%$24.88B$2.98B-70.296,772Gap DownHigh Trading VolumeTEVATeva Pharmaceutical Industries2.4766 of 5 stars$18.94+2.5%$24.71+30.5%+8.5%$21.73B$16.63B-118.3536,830Positive NewsSMMTSummit Therapeutics3.087 of 5 stars$25.98+9.2%$33.79+30.0%-40.7%$17.68BN/A-25.72110News CoverageInsider TradeGap UpGMABGenmab A/S3.8475 of 5 stars$27.54+0.6%$37.60+36.5%+3.4%$17.57B$3.12B13.842,682News CoveragePositive NewsASNDAscendis Pharma A/S3.1937 of 5 stars$205.91+3.9%$244.36+18.7%+64.0%$12.60B$490.75M-39.911,017Positive News Related Companies and Tools Related Companies SNY Alternatives GSK Alternatives TAK Alternatives ARGX Alternatives INSM Alternatives BNTX Alternatives TEVA Alternatives SMMT Alternatives GMAB Alternatives ASND Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:ONC) was last updated on 9/14/2025 by MarketBeat.com Staff From Our PartnersTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredWhat President Trump’s Executive Order 14154 means for your moneyA new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredApple’s falling behindApple just posted record-breaking results, yet its stock barely moved — because in today’s market, investors o...Porter & Company | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | Sponsored$15 Fund: Turn Gold Boom into Real IncomeIf you've been watching gold's historic run and wondering if it's too late… I've got good news. Because the...Investors Alley | SponsoredThe $17B signal no one expected…After SpaceX struck a $17 billion deal with EchoStar for a block of radio frequencies, tech analyst Jeff Brown...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding BeOne Medicines Ltd. - Sponsored ADR Please log in to your account or sign up in order to add this asset to your watchlist. Share BeOne Medicines With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free ONC Stock Alerts